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Abstract
Objective
To assess the effectiveness of community-wide deployment of insecticide–impregnated col-
lars for dogs- the reservoir of Leishmania infantum–to reduce infantile clinical visceral leish-
maniasis (VL).
Methods
A pair matched–cluster randomised controlled trial involving 40 collared and 40 uncollared
control villages (161 [95% C.L.s: 136, 187] children per cluster), was designed to detect
a 55% reduction in 48 month confirmed VL case incidence. The intervention study was
designed by the authors, but implemented by the Leishmaniasis Control Program in NW
Iran, from 2002 to 2006.
Results
The collars provided 50% (95% C.I. 17�8%–70�0%) protection against infantile VL incidence
(0�95/1000/yr compared to 1�75/1000/yr). Reductions in incidence were observed across
76% (22/29) of collared villages compared to pair–matched control villages, with 31 fewer
cases by the end of the trial period. In 11 paired villages, no further cases were recorded
post–intervention, whereas in 7 collared villages there were 9 new clinical cases relative to
controls. Over the trial period, 6,835 collars were fitted at the beginning of the 4 month sand
fly season, of which 6.9% (95% C.I. 6.25%, 7.56%) were lost but rapidly replaced. Collar
coverage (percent dogs collared) per village varied between 66% and 100%, with a mean
annual coverage of 87% (95% C.I. 84�2, 89�0%). The variation in post-intervention clinical
VL incidence was not associated with collar coverage, dog population size, implementation
logistics, dog owner compliance, or other demographic variables tested. Larger reductions
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and greater persistence in incident case numbers (indicative of transmission) were
observed in villages with higher pre-existing VL case incidence.
Conclusion
Community–wide deployment of collars can provide a significant level of protection against
infantile clinical VL, achieved in this study by the local VL Control Program, demonstrating
attributes desirable of a sustainable public health program. The effectiveness is not dissimi-
lar to the community-level protection provided against human and canine infection with L.
infantum.
Author summary
Zoonotic visceral leishmaniasis is a sand fly-borne disease of humans and dogs caused by
the intracellular parasite Leishmania infantum. Dogs are the proven reservoir. The disease
is of global health significance, and usually fatal unless treated. There are limited options
to reduce transmission. Insecticide-treated dog collars have been shown to protect dogs
against infectious bites from sand fly vectors, resulting in reductions of new infections in
both dogs and humans. However, there have been no studies to demonstrate the public
health benefits of this approach i.e. the impact on clinical VL incidence. This study
assessed the effectiveness of community-wide deployment of insecticide–impregnated
collars on dogs to reduce the incidence of clinical visceral leishmaniasis in children, the
high risk age-group. Collars were fitted to dogs in 40 endemic villages over 4 consecutive
years by the regional public health authorities in NW Iran. The case incidence of infantile
visceral leishmaniasis in these villages was compared to that in 40 untreated villages at the
end of the intervention period. The community-wide deployment of collars proved to
provide a 50% reduction in the development of the disease in children. This effect was
achieved under the operational conditions of the regional routine health authorities. We
conclude that the implementation of insecticide-impregnated collars should be consid-
ered in strategic scale-up operations against zoonotic visceral leishmaniasis.
Introduction
Visceral leishmaniasis (VL) is a protozoan vector–borne parasitic disease of humans following
infection with Leishmania donovani or L. infantum, characterized by prolonged fever, wasting,
splenomegaly, and hepatomegaly, and>95% case–fatality in the absence of treatment[1].
Leishmania are transmitted by female phlebotomine sand flies. Leishmaniasis is a Neglected
Tropical Disease (NTD) strongly associated with poverty and malnutrition[2], resulting in a
global incidence of 50,000 to 90,000 new VL cases per year[1]. Difficulties in reducing VL case
burdens arise due to the current lack of a human vaccine, limited safe therapeutic drugs, need
for improved vector control, and a better understanding of transmission dynamics[3–5].
VL due to L. donovani is anthroponotically transmitted, whereas VL due to L. infantum is a
zoonosis involving infectious domestic dog reservoirs[6], and uncertain role of humans[7], in
maintaining transmission[8]. Otherwise traditionally known as “infantile VL”, zoonotic VL is
a disease mainly of young children[9–14], although case age-distributions may vary e.g. [15,
16].
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Regional VL control programs focus on human case detection and treatment, adult sand fly
vector control, and for dogs, optional strategies including canine vaccination, topical insecti-
cide protection, chemotherapeutic treatment, or euthanasia[17–19]. Anthroponotic VL has
been targeted for elimination as a public health problem (<1 case/10,000 people per year at
district levels) in the Indian subcontinent by 2020, with substantial investment, technical and
political support[3, 5, 20]. This has contributed to significant reductions in incidence between
2012 and 2017 [1, 12, 21]. In contrast, investment to reduce zoonotic VL in endemic Latin
America, central Asia and Caucasia, are minimal by comparison; no such reductions in inci-
dence are observed notably in the Americas where>90% of cases occur [22, 23].
Vector and animal reservoir control are necessary to reduce zoonotic VL incidence as treat-
ment of human clinical cases, though necessary, is unlikely to impact on the transmission
cycle. Insecticides topically applied to dogs as slow release insecticide–impregnated collars
have been extensively tested in different regions, showing that they are effective against sand
fly vectors[24–28], and reduce infection risk in dogs[29–37]. Evidence that collars also can
reduce human infection incidence is limited to a single cluster randomized trial conducted in
NW Iran[31]. However, there are no peer-reviewed studies to test the impact of this approach
on human clinical VL disease.
In collaboration with the regional VL control program authorities in NW Iran, and with
access to VL case records provided by the Ministry of Health (MoH), we had the opportunity
to evaluate the impact of community–wide distribution of collars against clinical VL incidence,
and as conducted under operational conditions. The principal aims of the study were (i) to
measure the efficacy of the collar intervention against VL case incidence; (ii) to evaluate the
operational logistics of collar implementation; and (iii) to assess likely causes for the variation
in intervention effectiveness.
Methods
Study location
The study was conducted in the rural communities of the Kalaybar and Ahar administrative
districts of East Azerbaijan province, NW Iran (38688131N; 4321696E) from 2002 to 2006. Vil-
lages were located at altitudes of 369-1305m (Table 1). The main economic activity in the area
is agriculture, cash crops and particularly sheep farming. Dogs are kept as shepherd dogs or
household guard dogs, and small numbers of livestock (sheep, goats, cattle, chickens) are kept
in shelters variably near or attached to houses. Houses are constructed of plastered or unplas-
tered stone, cement, or brick, and rooves constructed of cement, thatched or corrugated iron.
Dried manure is generally stocked in piles away from houses as a source of fertilizer and fuel.
Temperatures ranged from 1˚C (in January) to 23˚C (in July/August), and rainfall from 18mm
(in August) to 76mm (in May).
In the region, 100–150 new VL cases were reported annually between 1998 and 2005, repre-
senting 45% of the total VL cases in Iran, the vast majority being children <10yrs of age[9–11,
38]. At the time of the study, pediatric L. infantum infection incidence measured by Direct
Agglutination Test (DAT) seroconversion was 2�4% compared to 1.9% by Leishmanin skin
test (LST) reaction [31]. Canine DAT seroconversion incidence was 7%[31], with reported
regional seroprevalences of 11%-22% [31, 38, 39]. In the same locations, the canine to human
seroprevalence ratio was 1.4: 1 (11% vs 8%)[31] compared to 3.1:1 (22% vs 7%) six years earlier
in 1995[39]. Transmission is predominantly peridomestic, with human exposure being inde-
pendent of age and sex, and associated with endophilic Phlebotomus sand fly vectors and
infected dogs[39–43]. The risk of childhood Leishmania seropositivity is associated with dog
ownership, village dog density (28/km2, 95% C.I.: 23.6–32.1), and the dog to human ratio[39].
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Two species of sand fly, Phlebotomus (Larroussius) perfiliewi transcaucasicus and Ph. (L.) kan-
delakii, are likely vectors in this region, being seasonally active for 4 months (late June to Octo-
ber)[41, 44].
The VL control program hinges on the District Ministry of Public Health (DTARH) which
is responsible for the District Health Centers (DHCs) in Kalaybar and Ahar. These centers
coordinate activities of 12 provincial Rural Health Centers (RHCs), which are run by trained
medical staff and health officers. Each RHC supervises about ten village health posts (khaneh
behdasht) where resident Health Promoters (behvarz) are responsible for disease surveillance,
control implementation, and facilitate suspect VL cases attendance at the RHCs. The RHCs
provide free VL diagnostic testing and treatment services, and refer those needing more spe-
cialist hospitalization to the DHCs or district hospital. Clinical VL is a notifiable disease.
Study design
Randomisation and treatment allocation. The trial was designed as a pair–matched clus-
ter randomised trial[45]. Villages were designated as clusters and selected in a two–step proce-
dure (Fig 1). All 417 endemic villages in the two districts, and confirmed VL case numbers in
the 4�5 years prior to the intervention (January 1998– June 2002) were listed. The inclusion cri-
teria for village recruitment were that the population size was>100, at least one confirmed
clinical VL case was recorded in this period, and that the village population was not nomadic.
A total of 91 villages met these criteria.
Following consultation by the RHC supervisors with village leaders and health workers, 80
of the more accessible villages were finally recruited. Ranked in descending order of pre–inter-
vention VL incidence, the top two villages were paired and randomly assigned to the treatment
(collars) or control (no collars) group by tossing a coin in the presence of observers. All
Table 1. Demographic characteristics of trial villages (clusters).
Collar arm Control arm
Total numbers per arm
Villages 40 40
Human population 22904 22844
Children 0–10 yrs 6341 6562
Households 3760 4011
Dogs 1962 1670
Houses with�1 dog 1364 1387
Geometric mean (95% C.L.s) per village Wilcoxon rank-sum z P�
Proportion of the population 0–10 yrs 0�27 (0�256, 0�283) 0�29 (0�270, 0�301) 1.29 0.190
M: F sex ratio children 0–15 yrs 0�99 (0�921, 0�106) 1�03 (0�978, 1�09) 0.85 0.394
Ratio shepherd: guard dog per village 0�45 (0�350, 0�589) 0�46 (0�344, 0�570) 0.55 0.389
Households per village 72 (56�4, 91�4) 82 (66�9, 100�8) 1.00 0.319
Humans population per village 469 (383�3, 574�2) 478 (392�9, 580�4) 0.20 0.840
Children 0–10 yrs per village 126 (101�1, 157�7) 136 (112�0, 165�6) 0.50 0.620
Dogs per village 43 (36�5, 50�2) 37 (31�5, 43�6) 0.69 0.488
Ratio dogs to children 0�34 (0�256, 0�449) 0�27 (0�209, 0�354) 0.20 0.229
Proportion population literate 0�40 (0�356, 0�444) 0�48 (0�417, 0�545) 1.40 0.088
Proportion population employed 0�21 (0�189, 0�241) 0�27 (0�200, 0�258) 0.83 0.408
Proportion houses with dog 0�39 (0�300, 0�522) 0�35 (0�266, 0�467) 0.33 0.740
Village altitude (m) 664 (544�4, 810�2) 674 (594�7, 763�5) 0.46 0.591
Ratio dogs to human 0�09 (0�070, 0�118) 0�08 (0�059, 0�102) 1.09 0.275
https://doi.org/10.1371/journal.pntd.0007193.t001
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subsequent pairs were similarly assigned alternately to either the treatment or control group,
resulting in 40 control and 40 pair-matched villages.
The pre–intervention DTARH house–to–house survey indicated that the collar and con-
trol villages (clusters) were demographically well balanced (Table 1). Although Iran has a
national Leishmania control program, during the trial period neither insecticide spraying,
canine test–and–slaughter, nor VL health education programs were conducted in the
Fig 1. Trial design.
https://doi.org/10.1371/journal.pntd.0007193.g001
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enrolled communities. However, 27 stray dogs were removed by the authorities (11 and 16
dogs from five and seven control and collar villages, respectively).
The intervention. Dog collars impregnated with 40mg/g deltamethrin (Scalibor Protec-
torBand, Intervet International, Boxmeer, Netherlands), were fitted to household dogs in the
40 treatment villages in late June/early July in each of four consecutive years (2002–2005).
The Scalibor collar label claimed 5–6 months insecticidal activity[25, 26] which exceeded the
annual transmission season.
The intervention was implemented by DTARH operational DHCs in Kalaybar and Ahar.
The collars were donated by Intervet, and given to the DHCs who distributed them to the
village Health Promoters, ensuring that sufficient collars and replacements were supplied
each year. Health Promoters conduct routine house–to–house visitation forming part of the
DTARH public health advisory and monitoring system. On these visits, they fitted the collars
to dogs, promoted the correct use of the collars, recorded the daily numbers of collars fitted,
lost, replaced, or refusals to fit collars (defined here as non-compliance), and identified any
adverse clinical effects reported by dog owners. The authors helped train the Health Promoters
to systematically record these events.
VL case definition and reporting. Confirmed clinical VL case numbers were extracted
from secondary records provided by DTARH. At the time of the study, the DTARH proto-
col stated that suspect VL cases were considered confirmed if they presented clinical signs
including prolonged fever, lymphadenopathy, and hepatosplenomegaly, associated with a
positive DAT (threshold �1/3200 titer), and/or microscopic detection of Leishmania in
clinical aspirates. All confirmed cases received treatment following WHO guidelines[12].
Based on parasite infections found in sand flies[42], Leishmania tropica is also transmitted
in the region. However, this parasite typically causes cutaneous infections, does not nor-
mally induce DAT seroconversion, and the distinctive clinical signs are known by the
DHCs.
Data management and masking. DTARH collated details of confirmed VL incident cases
which were provided to the authors anonymised accompanied by records of the patient’s age,
sex, village of residence, and date when they first presented at the medical center.
Lacking placebo collars, the village Health Promotors were not blinded to the intervention,
but the clinicians and DTARH data managers who collated the case data were.
Trial outcomes. The primary outcome for analysis was the cumulative number of inci-
dent VL cases per village by the end of the 48 months follow–up period. The transmission sea-
son of infection was attributed based on the date of the patient’s initial presentation: dates
falling between Julyyear × and end of Juneyear ×+1 were assigned to transmission seasonyear ×.
This interval allowed for a�9 month incubation period which exceeds the usual 2–6 months
incubation period reported in Iran and elsewhere[38].
Sample size calculations. The study was statistically powered to detect a 55% reduction in
the 48 month clinical VL incidence in collar clusters compared to control clusters, from base-
line 0.004 (~3.978 cases per 1000 children�10yrs old/yr) calculated for the 4�5 yr pre–inter-
vention period in the 80 trial clusters, and a surveyed harmonic mean of 106 children per
cluster. Data from the previous collar trial in the region[31], gave an inter–cluster coefficient
of variation of κ = 0�124 indicative of the degree of cluster pairwise matching achievable. We
applied a more conservative κ = 0�25 in power calculations. Under these assumptions, 38 clus-
ters per arm were required to achieve a power of 90% with α = 0�05 to reject the null hypothe-
sis. The final number of clusters enrolled was 40 clusters per arm. Comparison of unpublished
DTARH and published[39] demographic records showed that the village humans and dog
populations were generally stationary and stable.
Cluster randomised trial against leishmaniasis
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Statistical analysis
The intervention effect was computed using random–effects Poisson regression to test differ-
ences in the cumulative numbers of incident VL cases per cluster (= village), expressed as an
incidence risk ratio (IRR). The model included variables describing the trial design: the attrib-
uted year of infection, the log10 transformed childhood baseline village incidence, and the
pair–matching structure (as a cluster term). The number of children�10yrs per village, being
the well documented high risk group, was set as the model offset parameter. The variance
in cluster ratios of children to total population size were similar between treatment arms
(Table 1). Additional demographic variables, listed in Table 1, were then individually tested by
log–likelihood ratio test [LRT] of nested models, as potential modifiers of the unadjusted inter-
vention effect estimates.
A secondary analysis following[45] tested the normalized residuals of the observed
/expected case ratios for pair-matched clusters (Supplementary S1), where the expected num-
ber of cases per cluster were generated first by fitting the Poisson model, simultaneously
adjusting for significant covariates as described above, but excluding the intervention term.
Then, normalized (square root transformed) residuals of the observed /expected case ratios
were tested by Student’s paired t-test where the results of each cluster are given equal weight-
ing[45]. Differences in these ratios were also confirmed by applying a non–parametric two–
sided weighted signed rank test.
The relationship between post-intervention VL incidence differences between pair-
matched villages, and pre-intervention incidence, was examined by linear regression (illus-
trated in Fig 4). The relationships between village incidence pre–and post–intervention was
evaluated by negative binomial regression (nbreg), and by Spearman’s rank correlation (illus-
trated in Fig 5).
Data were analysed in Stata v.15.1 (StataCorp LP, College Station, TX).
Ethical considerations
The trial protocol was approved by the Regional Committee of Medical Ethics, Tabriz Univer-
sity of Medical Sciences, Iran. The University of Warwick’s Biomedical and Scientific Research
Ethics Committee (BSREC) confirmed that the trial raised no significant ethical concerns due
to its use of secondary anonymised human case data. There was no local animal ethical com-
mittee at the time of the study. Informed written consent was obtained from village leaders,
and from dog owners to fit collars, and dogs were monitored on a regular basis by village
Health Promotors for any adverse reactions to the collars.
Results
In the 4�5 years prior to the intervention (January 1998– June 2002), 113 confirmed clinical
VL cases were reported in a population of 6,562 children in the 40 control villages, with an
average annual case incidence of 3�83 per 1000. In the 40 collar villages during the same period,
118 cases were recorded amongst 6,341 children, an average incidence of 4�14 per 1000. These
rates were not significantly different (IRR = 1�04 [95% C.L.s 0�802, 1�344], p>0�77).
During the 48 month intervention period, 24 compared to 46 clinical VL cases were
recorded in the collar and control arms, respectively. The corresponding incidences were 0�95/
1000/yr and 1�75/1000/yr. Accounting for a general decline in VL case numbers over the years
of observation in both trial arms (Fig 2), there was a significant cumulative protective effect
attributed to the collar intervention (LR test: χ2(1) = 7�83, p = 0�0051). The trial design–
adjusted incidence risk ratio (IRR) was 0�50 (95% C.I. 0�300, 0�822) (model fit: Wald χ2(5) =
25�7, p<0�0001), equivalent to 50% (95% C.I. 17�8%, 70�0%) protection against clinical VL.
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The intervention effect was further confirmed by showing a significantly lower than expected
number of cases in collared vs control villages (Student’s t = -3.39, df = 39, p = 0�0016) (Supple-
mentary S1). The non–parametric sign rank test of these residuals was also significant (p =
0�008).
Additional demographic variables (listed in Table 1) were individually tested for effect
estimate modification, but none of the variables significantly improved the model fit (LRT:
χ2(1) <1�92, p>0�187).
VL case characteristics
The median age of the 70 reported clinical cases during the trial period was 1.6yrs (range: 0.5–
5yrs), with M:F sex ratios of 25:21 and 12:12 in control and collar arms, respectively. There
were no significant differences in case age distributions between trial arms (Poisson regression:
z = -0�97, P = 0�331), nor between intervention years (non–parametric test for trend: z = -1�54,
p = 0�124).
Heterogeneities in the intervention effect
Year of intervention. The annual point estimates of the intervention effect suggested that
the protective effect steadily increased with time under intervention, though the case numbers
were low and the errors broad (Table 2).
Variation in the intervention effect between villages. By the end of the intervention, 12
(30%) of the 40 collar villages, compared to 24 (60%) of the 40 control villages, presented�1
clinical VL case, indicating a reduced risk also at the village level (IRR = 0�57 [95% C.I.s 0�372,
0�879], χ2(1) = 7�27, p = 0�007).
Eleven of the 40 paired–matched villages reported zero cases post–intervention in both
treatment arms. Of the remaining 29 pairs, 22 (76%) collared villages showed reductions
in incidence compared to the pair-matched control villages (Fig 3), with 11 new VL cases
recorded compared to 42 VL cases in the control villages. However, in seven collared villages,
Fig 2. Confirmed VL case incidence during the 1998 to 2005 transmission seasons in collar villages (black line,
N = 40) and control villages (red line, N = 40). Arrow represents when collars were fitted in late June/early July of
each year before the start of transmission.
https://doi.org/10.1371/journal.pntd.0007193.g002
Cluster randomised trial against leishmaniasis
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007193 March 4, 2019 8 / 19
there was an increase in incidence, with 13 VL cases compared to 4 cases in the pair-matched
control villages over the 4 year period.
The difference in post-intervention VL incidence between pair-matched villages attributed
to the intervention was negatively associated with their pre-intervention baseline incidence
(linear regression b = -0�427, z = -3�19, p<0.001) (Fig 4). This suggested that despite the gen-
eral decline in VL case numbers by the end of the study, the intervention had a larger impact
on higher compared to lower levels of pre-existing transmission intensity.
In the control arm, there was a positive association between village pre–and post–interven-
tion incidence (nbreg: b = 0�095, z = 1�86, p = 0�06; Spearman’s r = 0�420, p = 0�007) (Fig 5).
This relationship was interrupted by the intervention (nbreg: b = -0�107, z = -0�75, p = 0�45;
Spearman’s r = -0�109, p = 0�50) (Fig 5).
Collar coverage
Over the trial period, 6,835 dogs were fitted with collars before the beginning of the sand fly
season (1,682, 1,722, 1,689, and 1,742 dogs annually in the 4 years). Of these, 6.9% (95% C.I.
6.25%, 7.56%) were lost per year, respectively 7�3% (123/1,682), 6.4% (110/1722), 6.9% (117/
1689) and 7.0% (122/1742). The mean annual coverage (percent of total dogs collared) was
87% (95% C.I. 84�2, 89�0%) being consistent across years (Kruskal–Wallis test: χ2(3) = 0�260,
p = 0�967), although it varied significantly between villages (range: 65�7%–100%) (Kruskal–
Fig 3. Frequency distribution of the absolute differences in post–intervention VL case incidence per 1000 between the 40 pair–
matched collar and control villages. Negative differences represent a reduction in incidence attributed to the collar intervention.
Positive changes represent an increase in incidence in the collar compared to the pair–matched control village. Values calculated as
(post incidence collar–control) for pair–matched villages.
https://doi.org/10.1371/journal.pntd.0007193.g003
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Fig 4. The absolute differences in the post–intervention period VL case incidence per 1000 between the pair–matched collar
and control villages. Villages were pair–matched based on their pre–intervention incidence as described in the Methods, and
ordered from low to high (Y axis: numbers 1–40). Dashed line: least squares linear fit from regression of the post–intervention
incidence difference against the pre–intervention incidence.
https://doi.org/10.1371/journal.pntd.0007193.g004
Cluster randomised trial against leishmaniasis
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Wallis test: χ2(39) = 0�122, p = 0�0001) (Fig 6). Coverage in any single village and year was not
associated with the village dog population size (z = 1�14, p = 0�26).
The variation in post-intervention VL incidence between pair-matched villages were not
associated with the mean or variance in village collar coverage (t<0.67, p>0.51, r2 = 0.008);
similar coverage was observed in villages with no incident VL cases, as those with >0 incident
VL cases (Fig 6).
Intervention logistics
Collar fitting, loss and replacement rates. Based on the most complete daily records
(2002 data), collars were distributed by the DHCs to all village Health Promoters within 16
Fig 5. Association between the pre–and post–intervention incidence per 1000 in the 40 control and 40 collar
villages. Line: least squares linear fit from regression of the post–intervention incidence against the pre–intervention
incidence, weighted by number of children in the denominator (symbol size).
https://doi.org/10.1371/journal.pntd.0007193.g005
Table 2. Crude and adjusted clinical VL incidence risk ratios (IRR), and observed number of confirmed VL cases, per year under intervention.
Year of intervention IRR (95% CLs) adjusted for trial design
characteristics1
IRR (95% CLs) unadjusted for trial design
characteristics2
VL cases (number in collar/control
arm)3
2002 0�69 (0�31, 1�57) 0�74 (0�33, 1�66) 10/14
2003 0�51 (0�23, 1�16) 0�55 (0�24, 1�23) 9/17
2004 0�19 (0�06, 0�67) 0�21 (0�06, 0�71) 3/15
2005 – – 2/0
Average across 2002–
2005
0�50 (0�30, 0�82) 0�54 (0�33, 0�88) 24/46
1 computed by fitting the RE Poisson model adjusted for trial design characteristics
2 computed from analysis of the raw annual risk ratios in absence of trial design characteristics
3 observed number of confirmed VL cases
https://doi.org/10.1371/journal.pntd.0007193.t002
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days at the start of the study. Aligned from the date (19th June 2002) of supply to the first vil-
lage, all collars were fitted in the 40 villages within one month.
In individual villages, all collars were fitted within a median 14 days (IQR 12.3–14.0;
range: 4–30 days) from collar provision, with>70% in place within eight days. The number
of dogs per village did not influence either the total fitting time (quantile regression: t = 0�95,
p = 0�348) or daily fitting rates (comparison of daily slope interactions: z<0�71, p>0�54). Fit-
ting rates were similar for guard and shepherd dogs (Two-sample Wilcoxon rank-sum test: z =
-0.262, p = 0.794).
Collars were lost in 35 of the 40 collar villages, 2–147 days post-fitting. A median 3 (IQR
2–4; range 1–10) collars were lost per village. However, these were rapidly replaced: 59%
within 4 days, and 91% within 8 days.
Fig 6. Association between the intervention effect on pair–matched collar and control village incidence per 1000 and the village
annual collar coverage level (circles). Y axis error bars represent the minimum and maximum annual dog collar coverage per
village over the 4 years intervention.
https://doi.org/10.1371/journal.pntd.0007193.g006
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Discussion
The effectiveness of insecticide–impregnated collars against human clinical VL had not been
trialled as a potential public health control option. Community–wide collar coverage over 4
transmission seasons reduced the relative risk of infantile VL by 50% (95% C.I. 30%, 82%), and
reduced the total VL case numbers by 48% during the intervention period.
The protective effect was clear despite a 70% general decline in reported case numbers over
the study period, the decline being consistent with national trends from the late 1990s to 2014
in Iran[9] and elsewhere: waxing and waning cycles in incident case numbers are reported in
the Indian subcontinent[5], with speculation over the regulating mechanisms[46]. In Iran, VL
is a notifiable disease, subject of major public health programs, and well known to physicians
in the study region. Development of VL from subclinical infection in the region is 8% (1 in 13
infections), where conversion risk declines with age associated with a rise in cell–mediated
immunity[40]. The observed VL cases were�5yrs old, similar to the VL age–distributions
throughout Iran[9–11]. This contrasts to the older average age groups afflicted with VL due to
L. donovani infection[47], and in immunocompromised VL patients generally[16]. Tradition-
ally a disease of children, variability in L. infantum VL case age distributions are appearing
[23].
All eight published studies designed to evaluate the efficacy of Scalibor collars, demon-
strated reduced canine seroinfection incidence by 46%–86% within 1–2 years of use[30–35, 37,
48]. They have been shown to reduce also sand fly densities[27], and sand fly infection preva-
lence with L. infantum[48]. The DTARH program did not monitor changes in canine infection
rates or sand fly densities during the trial period, which is one limitation of this study. How-
ever, a previous cluster randomized trial of community-wide distribution of Scalibor collars in
the study region, reported protective effects against canine infection of 54% [95% C.L.s 30%,
70%]), associated with a reduction in infection (cf. clinical disease) incidence of 43% (95% C.L.
s 10%, 63%) in�10yr old children[31]. What was not clear from that study, was whether
reductions in seroconversion would directly translate into reductions in clinical VL incidence.
Scalibor collars release deltamethrin into dermal secretions, resulting in reduced sand fly
blood–feeding by>90%, and increased mortality in blood–fed sand flies by 35%–100% over 8
months[25, 26]. More recent studies suggest that Scalibor collars offer 94–98% protection
against Phlebotomous perniciosus sand fly bites for up to 12 months[49]. These effects reduce
the likelihood of a collared dog acquiring infection and being a source for onward transmis-
sion, thus, they are expected to reduce the number of infectious bites on humans. The risk of
clinical development is associated with elevated parasite burdens and immune responses[50,
51]; collars may also reduce the metacyclic inoculum delivered by vectors, and/or the initial
amastigote infection burdens, sufficient to reduce the subclinical to clinical VL conversion
rate. Lower incident anti–Leishmania antibody titers, observed in seronegative collared dogs
[32], support this hypothesis.
The annual effect estimates in this study suggest that one to two years of continued inter-
vention achieved a similar outcome to the 4-year cumulative effect. However, the point esti-
mate errors were broad as the study was not statistically powered to detect significant changes
in any single transmission season. Interpretation of the effect estimates over time was further
hindered by the very low VL case numbers in both arms and inevitable stochastic events in the
latter years of the study. A different cyclical pattern of VL between control and intervention
villages is unlikely to have occurred due to the randomization of trial clusters.
Clinical VL cases continued to be notified in villages during the years of collar use, indicat-
ing that collars were not wholly effective in interrupting transmission. Villages with higher
pre–intervention incidence were more likely to experience continued transmission, despite
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achieving greater relative reductions in disease incidence compared to villages of low pre–
intervention incidence. This raises the possibility that the collar coverage was insufficient in
some villages.
Collar coverage showed significant variation between villages with some being consistently
low. Changes in village VL incidence was not associated with village coverage, nor indeed with
any demographic variable. In three of the seven collared villages where the intervention failed
to prevent a higher number of incident cases compared to controls, annual collar coverage was
>84% (average c.90%); and in all except one of the 7 villages, the minimum annual coverage
was>77%. Therefore, we do not attribute these failures to lower collar coverage levels. Nor do
we attribute it to collar losses or to non–compliance (owner refusing to have collars fitted to
dogs). Short–term allergic dermal reactions to deltamethrin, reported in 2%–16% of collared
dogs in two Brazilian studies[32, 37], usually cause owners to remove the collars. Such adverse
effects were not reported in this trial, nor in the previous trial in NW Iran[31]. Similarly,
there were no cases of dog owners refusing to have collars fitted to their dogs by the Health
Promoters.
Dogs�3m old were not collared (following label instructions) but represented <3% of
the canine population. The period of latency to infectious onset far exceeds the 4 month trans-
mission season[6], thus ruling out these dogs as significant reservoirs for continued transmis-
sion. Stray dogs were rarely seen (27 in total), equivalent to<0�2 dogs per study village year.
Although local wild canid populations can support infections[38], their densities are relatively
low, and the role of wild canids in maintaining transmission is disputed[8, 52, 53].
Potential scale-up and sustainability
A significant finding of this study was that the intervention effect was achieved under the oper-
ational conditions as implemented by the DTARH VL control program. After ensuring that
the design and village randomisation processes met CRT analytical requirements, the authors
had minimal contact with authorities. The authors supplied known numbers of collars to the
DHCs who distributed them to the villages, and collated details of the collar implementation.
This provided the opportunity to measure the logistics and likely sustainability of program-
matic scale–up.
Collars were fitted within only 15 days of village supply, and collar losses were rapidly
replaced, suggesting coverage levels were maintained during the transmission seasons. Neither
coverage level nor time to complete collar fitting were related to the total number of dogs eligi-
ble for a collar, concluding that lower village coverage levels were not due to time constraints.
Feasibility of a regional–level scale–up was indicated by DTARH taking only 16 days to deliver
collars to all 40 villages spread over an area of 15,000km2, and total collars being fitted within
one month from collar provision to the first village.
Collars were socially accepted, visibly distinguished treated dogs, and should not require
replacement every 3–4 weeks, unlike alternative topical formulations. Coupled with the short
transmission season, effective collar duration, and rapid replacement rate, the feasibility of
effective sustainable scale–up is indicated. Collar losses in this region of between 1% per
month[31] and 1.7% (95% CI: 1.6%, 1.9%) per month (this study), were not substantially
higher than in other endemic regions: 0�8% in Brazil[37] and 0�6–0�7% in Italy[34, 54], though
exceptional rates, 7�8% and 8�2%, in both continents have been reported[32, 33].
Sustainability will be governed also by costs and cost–effectiveness. Considering the cost of
collars alone, in this study, collars were donated by the manufacturer. However, based on €14
per collar, the annual material cost would have equated to approximately €24,000, or €96,000
over 4 years. That is €4,364 per VL case averted compared to case numbers in the control arm.
Cluster randomised trial against leishmaniasis
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007193 March 4, 2019 14 / 19
This value is for a period with 70% relative decline in reported case numbers from the late
1990s to 2014[9]. Better cost–effectiveness may be expected as the cyclical waning in case num-
bers inevitably reverses in non–intervention regions.
One key knowledge gap is how best to implement dog collar programs: currently unknown
is the minimum community coverage level necessary to reduce transmission, equivalent to
vaccination coverage thresholds calculated to maintain herd immunity[55]. Mathematical
models suggest that increasing collar coverage from 70% to 90% could cause moderate to sub-
stantial reductions in both canine and human infection prevalences[32, 56, 57]. However,
three empirical studies that report coverage of 70%–100% failed to corroborate these predic-
tions[31, 34, 37]. Without known target thresholds, collar campaigns may result only in pro-
tection of the individual dog or its household.
Of relevance to NTD elimination strategies, our data suggest that greater initial reductions
in incidence may be achieved in communities with higher compared to lower preexisting
transmission pressure. One prediction is that by reducing transmission, infection in the lower-
prevalence settings becomes more clustered, thus more stable and more resilient to interven-
tions[58]. Approaching elimination will require different control strategies to those used in the
initial attack phase. For example, heterogeneities in household sand fly densities, and the trans-
mission potential of individual vectors and reservoirs[53, 59, 60], imply the need for high cov-
erage levels to encounter such transmission hotspots.
In conclusion, the results of this study promote the community-wide application of insecti-
cide–impregnated collars as a public health tool to reduce clinical VL burdens, not just human
and canine infection. The observed level of impact was achieved working within the existing
MoH infrastructure, demonstrating many desirable attributes of a potentially sustainable con-
trol program that could be scaled–up with minimal additional technical capacity training.
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